Lexaria Bioscience Corp Forecast, price target & analysts
Lexaria Bioscience Corp Target price 2025 - Analyst rating & recommendation
Lexaria Bioscience Corp Classifications & Recommendation:
Lexaria Bioscience Corp Price Target
| Target Price | $5.61 |
| Price | $0.98 |
| Potential |
473.62%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Lexaria Bioscience Corp 2026 .
The average Lexaria Bioscience Corp target price is $5.61.
This is
473.62%
register free of charge
$6.30
544.17%
register free of charge
$5.05
416.36%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Lexaria Bioscience Corp to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Lexaria Bioscience Corp stock has an average upside potential 2026 of
473.62%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Aug '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.46 | 0.49 |
| 100.00% | 7.02% | |
| Net Margin | -1,260.87% | -2,513.10% |
| 56.46% | 99.31% |
5 Analysts have issued a sales forecast Lexaria Bioscience Corp 2025 . The average Lexaria Bioscience Corp sales estimate is
This results in the following potential growth metrics:
5 Lexaria Bioscience Corp Analysts have issued a net profit forecast 2025. The average Lexaria Bioscience Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Aug '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.47 | -0.64 |
| 53.47% | 36.17% | |
| P/E | negative | |
| EV/Sales | 29.45 |
5 Analysts have issued a Lexaria Bioscience Corp forecast for earnings per share. The average Lexaria Bioscience Corp EPS is
This results in the following potential growth metrics and future valuations:
Lexaria Bioscience Corp...
Current Lexaria Bioscience Corp Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 25 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 02 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 25 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
